Seagen
SGEN
#555
Rank
HK$338.24 B
Marketcap
HK$1,793
Share price
-0.07%
Change (1 day)
70.40%
Change (1 year)

EPS for Seagen (SGEN)

EPS in 2023 (TTM): -HK$31.41

According to Seagen 's latest financial reports the company's current EPS (TTM) is -HK$31.43. In 2022 the company made an earnings per share (EPS) of -HK$25.87 an increase over its 2021 EPS that were of -HK$29.00.

EPS history for Seagen from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$31.4121.44%
2022-HK$25.87-10.81%
2021-HK$29.00-206.32%
2020HK$27.28-458.76%
2019-HK$7.60-31.69%
2018-HK$11.1363.22%
2017-HK$6.82-13%
2016-HK$7.846.38%
2015-HK$7.3751.61%
2014-HK$4.8619.23%
2013-HK$4.0810.64%
2012-HK$3.68-64.66%
2011-HK$10.42101.52%
2010-HK$5.17-27.47%
2009-HK$7.13-15.74%
2008-HK$8.4736.71%
2007-HK$6.195.33%
2006-HK$5.885.63%
2005-HK$5.56-59.89%
2004-HK$13.87139.19%
2003-HK$5.80-3.9%
2002-HK$6.04-24.51%
2001-HK$7.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.66-133.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.75-159.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$86.14-374.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.28-174.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.53-193.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-HK$2.82-91.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-HK$2.43-92.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.49-15.71%๐Ÿ‡บ๐Ÿ‡ธ USA